Tag: Contract Manufacturing

Contract manufacturing is a process that establishes a working agreement between two companies. As part of the agreement, one company custom produces parts or other materials on behalf of their client.

Takara Bio receives a manufacturing license from Swedish Medical Product Agency

stem cells
Takara Bio announced that the Medical Products Agency granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions.

Boehringer Ingelheim boosts its drug manufacturing capabilities in China

boehringer-ingelheim
Boehringer Ingelheim, a leading contract manufacturer for biopharmaceutical medicines, has rounded off its full-service capabilities for customers with a new filling line at Shanghai, China.

AVVA RUS invites for cooperation in the area of contract manufacturing

avva-rus
The company is ready to help both Russian developers to enter international markets and international companies to localize their products in Russia.

Novacap acquires PCI Synthesis CDMO

research
Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO).

Peptonic Medical and Orion CMO made a technology transfer agreement

biotechnology
Peptonic Medical AB (Sweden) entered a tech transfer agreement with Orion Contract Manufacturing Organisation (CMO) (Finland) to prepare for the commercial manufacture of VagiVital - a product that Peptonic plans to launch.

AMRI signs a seven-year contract with NIAID

api
AMRI, a global contract research, development and manufacturing organization, has secured a seven-year contract from the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, USA.

Avara buys the largest sterile manufacturing facility in Canada

sterile-manufacturing
Avara Pharmaceutical Services, a world-class contract development and manufacturing organization acquires the largest sterile manufacturing facility for injectable medicines in Canada from a leading global pharmaceutical company.

State Duma adopted a bill to simplify registration of drugs

drug development
It will be possible to register drugs that have the same international nonproprietary names, but different trade names, and being manufactured at the same site. The corresponding government bill was adopted by the State Duma.

Today’s realities in the development of local and contract manufacturing

forum
The representatives of pharmaceutical companies met at the forum of the Adam Smith Institute where they shared their views on the development of local and contract manufacturing.

The global CRO market reached $44.4 billion value in 2017

test tubes
According to report from The Business Research Company, the global market for clinical trial services to biopharmaceutical and medical device companies is forecast to grow at 12 per cent year on year to 2021.

Grand River Aseptic Manufacturing boosts its manufacturing capacity

pharma
Grand River Aseptic Manufacturing (GRAM), a leading parenteral contract development and manufacturing organization has announced its second major equipment purchase this year.

Mayne Pharma opened an oral solid-dose commercial manufacturing facility

pills
Mayne Pharma Group, a branded and generic pharmaceuticals company, opened new $80-million, oral solid-dose commercial manufacturing facility in Greenville, North Carolina, USA.

3P Biopharmaceuticals signed a contract manufacturing agreement with Intervacc

vaccine
3P Biopharmaceuticals, a Spanish biotechnology company, and the Swedish company Intervacc completed negotiations and signed the agreement for contract manufacturing of Strangvac®.

Rentschler Biopharma and Leukocare reported about effective cooperation

biopharmaceutical
Rentschler Biopharma SE, a leading contract development and manufacturing organization, and Leukocare AG, a biotechnology company, reported on the successful first year of their unique strategic alliance.

Samsung Biologics signed the first contract for its newly built Plant 3

samsung biologics
Samsung BioLogics entered into the first manufacturing contract for its Plant 3 facility. The approximate value of the contract is $148 million if the product will be successful in the clinic.

Richard Král was appointed as a new CEO of Saneca Pharma CDMO

Richard, who has been the sales and marketing director at Saneca for almost three years, has previously worked for GlaxoSmithKline and Zentiva Group.